Fiona Smythe 1/9/24 Fiona Smythe 1/9/24

Debiopharm Innovation Fund invests in MedaSystems

We are pleased to announce additional funding from Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, motivated by their vision of patient centric, data-enabled clinical research and enabling patients to access novel treatments sooner.

Fiona Smythe 10/12/23 Fiona Smythe 10/12/23

MedaSystems closes Seed Funding

We’re very pleased to share with you that MedaSystems has closed a seed funding round, in order to continue to grow our market and further build out the platform.

Matthew Rosen 10/5/23 Matthew Rosen 10/5/23

MedaSystems Demonstrates Continued Commitment to Protecting Expanded Access Data with Successful SOC 2 Type 2 Audit

We are thrilled to announce the successful completion of a Service Organization Control (SOC) 2 Type 2 audit. As industry leaders in the SaaS Expanded Access software sector, this accomplishment underscores our unwavering commitment to data security, patient privacy, and regulatory compliance.

Fiona Smythe 9/28/23 Fiona Smythe 9/28/23

Young Sohn joins MedaSystems’ advisory board

Industry veteran, Young Sohn, joins the advisory board of MedaSystems.

Matthew Rosen 1/24/23 Matthew Rosen 1/24/23

MedaSystems receives SOC 2 Type 1 certification

We are pleased to share that we’ve been SOC2 Type 1 certified.

Fiona Smythe 12/14/22 Fiona Smythe 12/14/22

MedaSystems welcomes Dr. Jean Godin as advisor

Dr. Jean Godin joins MedaSystems as a strategic advisor.

Fiona Smythe 11/11/22 Fiona Smythe 11/11/22

MedaSystems welcomes Lisa Suennen to board of advisors

We’re thrilled to announce that Lisa Suennen has joined our board of advisors. Ms. Suennen is the President of Digital and Data Solutions at Canary Medical. She brings her deep expertise in digital health, technology, and life sciences to bear on MedaSystems’ mission to help life science companies collaborate with physicians and their patients seeking early access to investigational medicines.